Kala Pharmaceuticals

Kala Pharmaceuticals Has Received $11.5m in Series a Equity Financing Round
Mar 5, 2013
Kala Pharmaceuticals, a developer of products that effectively penetrate the mucosal barrier to treat various debilitating diseases, has received $11.5m in Series A equity financing round, led by new and existing investors. Kala said ...

Tags: Kala Pharmaceuticals, drugs, ocular diseases drugs